Loading clinical trials...
Loading clinical trials...
In Tunisia, diabetes is a serious public health problem, its prevalence reaches 22.9% of people aged 18 and over and is likely to affect a quarter of the population by 2045. Diabetic kidney disease is...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dacima Consulting
Collaborators
NCT06613854 · Type 2 Diabetes Mellitus (T2DM)
NCT07535307 · Diabetes Mellitus
NCT07224321 · Type 1 Diabetes Mellitus
NCT07222137 · Diabetes Mellitus, Type 1
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
Tunisian Society for Nephrology, Dialysis and Renal Transplantation
Tunis
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions